NCT00004872View on ClinicalTrials.gov

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

recombinant human endostatin

Trial Locations (1)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00004872 - Endostatin in Treating Patients With Advanced Refractory Solid Tumors | Biotech Hunter | Biotech Hunter